Current
23.7×
5-Year Average
20.1×
All-Time High
27.2×
All-Time Low
4.1×
EV/EBITDA daily chart for Baxter International (BAX)
Jun 8, 2021 – Jun 5, 2026 · 1,255 trading days
EV/EBITDA is not shown for periods when TTM EBITDA was negative.
Historical EV/EBITDA for Baxter International (BAX) from 2001 to 2025
| 2025 | $9.82B | $766.00M | 23.0× | -0.8× | |
| 2024 | $14.87B | $1.12B | 23.8× | +5.7× | |
| 2023 | $19.60B | $1.69B | 18.1× | — | |
| 2022 | $25.69B | −$705.00M | — | — | |
| 2021 | $43.01B | $2.57B | 22.7× | +3.3× | |
| 2020 | $40.92B | $2.27B | 19.4× | -4.7× | |
| 2019 | $42.40B | $1.87B | 24.1× | +9.7× | |
| 2018 | $34.75B | $2.53B | 14.4× | -2.7× | |
| 2017 | $35.10B | $2.06B | 17.1× | +13.0× | |
| 2016 | $23.99B | $5.84B | 4.1× | -10.9× | |
| 2015 | $20.87B | $1.33B | 15.0× | +6.0× | |
| 2014 | $21.58B | $3.07B | 9.0× | +1.3× | |
| 2013 | $20.51B | $3.51B | 7.7× | +1.6× | |
| 2012 | $19.84B | $3.71B | 6.1× | +1.2× | |
| 2011 | $15.11B | $3.57B | 4.9× | -1.7× | |
| 2010 | $15.87B | $2.69B | 6.5× | +0.7× | |
| 2009 | $19.19B | $3.50B | 5.9× | -0.1× | |
| 2008 | $17.84B | $3.24B | 6.0× | -1.3× | |
| 2007 | $19.93B | $2.82B | 7.3× | +0.4× | |
| 2006 | $16.38B | $2.42B | 6.9× | -0.6× | |
| 2005 | $13.11B | $2.09B | 7.5× | -1.0× | |
| 2004 | $11.61B | $1.75B | 8.5× | +2.1× | |
| 2003 | $10.15B | $2.16B | 6.4× | +0.6× | |
| 2002 | $9.10B | $2.17B | 5.8× | -4.3× | |
| 2001 | $17.48B | $1.93B | 10.1× | — |
- 202523.0×
- 202423.8×
- 202318.1×
- 2022—
- 202122.7×
- 202019.4×
- 201924.1×
- 201814.4×
- 201717.1×
- 20164.1×
- 201515.0×
- 20149.0×
- 20137.7×
- 20126.1×
- 20114.9×
- 20106.5×
- 20095.9×
- 20086.0×
- 20077.3×
- 20066.9×
- 20057.5×
- 20048.5×
- 20036.4×
- 20025.8×
- 200110.1×
About EV/EBITDA at Baxter International (BAX)
Baxter International (BAX) EV/EBITDA ratio is 23.7× as of June 5, 2026. The 5-year average is 20.1×. The sector median currently stands at 15.0×. The current ratio is at the 95th percentile of its own 10-year history.
Baxter International (BAX) historical EV/EBITDA ratio has ranged from a low of 4.1× (2016) to a high of 27.2× (2025) in the available daily series.
The EV/EBITDA ratio (the enterprise multiple) compares enterprise value (EV) to trailing twelve-month (TTM) EBITDA. EV is calculated as market capitalisation + total debt − cash & short-term investments. Because EV/EBITDA is capital-structure-neutral and ignores non-cash depreciation and amortisation, it is the standard multiple used in M&A and for cross-company or cross-border comparisons. Note: this calculation uses a simplified EV (minority interest and preferred equity excluded due to data availability), consistent with most public financial-data providers.
Baxter International EV/EBITDA by Year
Baxter International EV/EBITDA 2025: 23.0×
Baxter International (BAX) EV/EBITDA ratio in 2025 was 23.0×, contracted from 23.8× the prior year.
Baxter International EV/EBITDA 2024: 23.8×
Baxter International (BAX) EV/EBITDA ratio in 2024 was 23.8×, expanded from 18.1× the prior year.
Baxter International EV/EBITDA 2023: 18.1×
Baxter International (BAX) EV/EBITDA ratio in 2023 was 18.1×, contracted from 22.7× the prior year.
Baxter International EV/EBITDA 2021: 22.7×
Baxter International (BAX) EV/EBITDA ratio in 2021 was 22.7×, expanded from 19.4× the prior year.
Baxter International EV/EBITDA 2020: 19.4×
Baxter International (BAX) EV/EBITDA ratio in 2020 was 19.4×.
EV is calculated as Market Cap + Total Debt − Cash & Short-Term Investments (simplified). Minority interest and preferred equity are excluded due to data availability. This is consistent with the methodology used by most public financial data providers.
Sector peers by EV/EBITDA — chart
Current ratio vs. sector peers. Highlighted bar is this company.
Sector peers by EV/EBITDA — table
Healthcare peers of Baxter International (BAX), ranked by EV/EBITDA ratio.
| 13.9× | |
| 13.6× | |
| 13.6× | |
| 13.2× | |
| 12.9× | |
| 12.9× | |
| 12.7× | |
| 12.4× | |
| 12.0× | |
| 11.7× | |
| 11.5× | |
| 11.5× | |
| 11.2× | |
| 10.5× | |
| 10.0× | |
| 8.8× | |
| 8.5× | |
| 8.2× | |
| 7.9× | |
| 7.8× | |
| 6.8× | |
| 6.5× | |
| 5.8× | |
| 5.7× | |
| 4.5× |
- 13.6×
- 13.2×
- 12.9×
- 12.4×
- 12.0×
- 11.7×
- 11.5×
- 10.5×
- 10.0×
- 8.5×
- 8.2×
- 7.9×
- 7.8×
- 5.8×
- 4.5×
Frequently asked questions
Baxter International (BAX) Key Financials
Charts, filings, and peer comparison for every metric